A ALIMENTARY TRACT AND METABOLISM
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
|
C CARDIOVASCULAR SYSTEM
|
|
D DERMATOLOGICALS
|
D01 ANTIFUNGALS FOR DERMATOLOGICAL USE
|
D02 EMOLLIENTS AND PROTECTIVES
|
D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
|
D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
|
D05 ANTIPSORIATICS
|
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
|
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
|
D08 ANTISEPTICS AND DISINFECTANTS
|
D09 MEDICATED DRESSINGS
|
D10 ANTI-ACNE PREPARATIONS
|
D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE
|
D10AA Corticosteroids, combinations for treatment of acne
|
D10AB Preparations containing sulfur
|
D10AD Retinoids for topical use in acne
|
D10AD01 Tretinoin [DG:DG00433]
|
D00094 Tretinoin (JAN/USP/INN) <JP/US>
D01516 Tretinoin tocoferil (JAN) <JP>
|
D10AD02 Retinol [DG:DG00123]
|
D10AD03 Adapalene
|
D10AD04 Isotretinoin [DG:DG00434]
|
D10AD05 Motretinide
|
D10AD06 Trifarotene
|
D10AD51 Tretinoin, combinations
|
D10AD53 Adapalene, combinations
|
D10AD54 Isotretinoin, combinations
|
D10AE Peroxides
|
D10AF Antiinfectives for treatment of acne
|
D10AX Other anti-acne preparations for topical use
|
D10B ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE
|
D11 OTHER DERMATOLOGICAL PREPARATIONS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
J ANTIINFECTIVES FOR SYSTEMIC USE
|
|
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
L01 ANTINEOPLASTIC AGENTS
|
L01A ALKYLATING AGENTS
|
L01B ANTIMETABOLITES
|
L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
|
L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
|
L01E PROTEIN KINASE INHIBITORS
|
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
|
L01X OTHER ANTINEOPLASTIC AGENTS
|
L01XA Platinum compounds [DG:DG01679]
|
L01XB Methylhydrazines
|
L01XD Sensitizers used in photodynamic/radiation therapy
|
L01XF Retinoids for cancer treatment
|
L01XF01 Tretinoin [DG:DG00433]
|
D00094 Tretinoin (JAN/USP/INN) <JP/US>
D01516 Tretinoin tocoferil (JAN) <JP>
|
L01XF02 Alitretinoin
|
L01XF03 Bexarotene
|
L01XG Proteasome inhibitors [DG:DG03134]
|
L01XH Histone deacetylase (HDAC) inhibitors [DG:DG03133]
|
L01XJ Hedgehog pathway inhibitors [DG:DG01566]
|
L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors [DG:DG02942]
|
L01XL Antineoplastic cell and gene therapy
|
L01XX Other antineoplastic agents
|
L01XY Combinations of antineoplastic agents
|
L02 ENDOCRINE THERAPY
|
L03 IMMUNOSTIMULANTS
|
L04 IMMUNOSUPPRESSANTS
|
|
M MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
|
S SENSORY ORGANS
|
|
V VARIOUS
|